QTRX News and Press, Quanterix Corporation From 10/24/23

2023-10-24 06:43:50 ET More on Quanterix Quanterix: Advancing sNfL Reference Ranges In Pediatric Neurology Quanterix Corporation (QTRX) Q2 2023 Earnings Call Transcript Quanterix Corporation 2023 Q2 - Results - Earnings Call Presentation Quanterix upgraded to...

2023-10-02 09:41:23 ET More on Nvidia Nvidia Was Up 235% In 2023, Don't Expect It To Continue (Rating Downgrade) Nvidia: Strong Buy For The Godfather Of AI The AI Trade For Conservative Investors: Sell Nvidia And Buy ASML For further details see: Nvidia t...

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will speak on a panel at Goldman Sachs Alzheimer’s Disease Day on Tuesday, October 3, 2023. The panel, Infra...

2023-09-25 14:58:32 ET More on Quanterix Q uanterix: Advancing sNfL Reference Ranges In Pediatric Neurology Quanterix launches LucentAD biomarker test for early Alzheimer's disease Seeking Alpha’s Quant Rating on Quanterix Historical earnings data for ...

2023-09-25 09:59:16 ET More on Health Care Select Sector SPDR BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecuti...

2023-09-12 11:32:27 ET More on Quanterix Seeking Alpha’s Quant Rating on Quanterix Historical earnings data for Quanterix Financial information for Quanterix Quanterix: Advancing sNfL Reference Ranges In Pediatric Neurology Quanterix Corporatio...

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will take part in a fireside chat at the Morgan Stanley 21 st Annual Global Healthcare Conference on September ...

Quanterix Corporation (NASDAQ: QTRX) is the focus of IBN's latest stock spotlight. The company's shares have moved 0.15% on the day to $26.84. Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health fo...

2023-08-24 11:46:06 ET Summary Quanterix specializes in ultra-sensitive digital immunoassay platforms for early disease detection, potentially transforming disease management. The company's financials show promising growth, with total revenue increasing by 32% compared to the same...

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced that it appointed William (Bill) P. Donnelly to its Board of Directors. Mr. Donnelly brings many years of senior leadership exp...